FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Tray Thomas
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/11/2022 

3. Issuer Name and Ticker or Trading Symbol

INCYTE CORP [INCY]
(Last)        (First)        (Middle)

1801 AUGUSTINE CUT-OFF
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Principal Accounting Officer /
(Street)

WILMINGTON, DE 19803      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 3238 D  
Common Stock 1399 I By Spouse 
Common Stock 554 (1)D  
Common Stock 1886 (2)D  
Common Stock 2870 (3)D  
Common Stock 2322 (4)D  
Common Stock 3649 (5)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Incentive Stock Option (right to buy)  (6)1/6/2026 Common Stock 1044 $95.76 D  
Non-Qualified Stock Option (right to buy)  (6)1/6/2026 Common Stock 1730 $95.76 D  
Incentive Stock Option (right to buy)  (6)1/6/2023 Common Stock 1005 $95.76 D  
Non-Qualified Stock Option (right to buy)  (6)1/6/2023 Common Stock 2436 $95.76 D  
Non-Qualified Stock Option (right to buy)  (6)7/14/2026 Common Stock 2639 $83.83 D  
Incentive Stock Option (right to buy)  (6)1/16/2027 Common Stock 879 $113.64 D  
Non-Qualified Stock Option (right to buy)  (6)1/16/2027 Common Stock 2642 $113.64 D  
Non-Qualified Stock Option (right to buy)  (6)1/16/2027 Common Stock 2639 $113.64 D  
Non-Qualified Stock Option (right to buy)  (6)7/4/2027 Common Stock 1677 $128.34 D  
Incentive Stock Option (right to buy)  (6)1/22/2028 Common Stock 1 $94.63 D  
Non-Qualified Stock Option (right to buy)  (6)1/22/2028 Common Stock 1676 $94.63 D  
Incentive Stock Option (right to buy)  (6)1/23/2028 Common Stock 1048 $95.34 D  
Non-Qualified Stock Option (right to buy)  (6)1/23/2028 Common Stock 5443 $95.34 D  
Incentive Stock Option (right to buy)  (7)7/1/2028 Common Stock 1 $68.62 D  
Non-Qualified Stock Option (right to buy)  (8)7/1/2028 Common Stock 5172 $68.62 D  
Incentive Stock Option (right to buy)  (9)1/3/2029 Common Stock 1383 $72.27 D  
Non-Qualified Stock Option (right to buy)  (9)1/3/2029 Common Stock 3349 $72.27 D  
Non-Qualified Stock Option (right to buy)  (10)1/3/2029 Common Stock 5173 $72.27 D  
Non-Qualified Stock Option (right to buy)  (11)7/1/2029 Common Stock 2289 $85.01 D  
Non-Qualified Stock Option (right to buy)  (12)1/16/2030 Common Stock 2290 $80.50 D  
Incentive Stock Option (right to buy)  (13)7/1/2030 Common Stock 324 $106.47 D  
Non-Qualified Stock Option (right to buy)  (14)7/1/2030 Common Stock 1896 $106.47 D  
Incentive Stock Option (right to buy)  (15)1/14/2031 Common Stock 324 $90.56 D  
Non-Qualified Stock Option (right to buy)  (16)1/14/2031 Common Stock 1896 $90.56 D  
Incentive Stock Option (right to buy)  (17)7/1/2031 Common Stock 815 $83.58 D  
Non-Qualified Stock Option (right to buy)  (18)7/1/2031 Common Stock 1808 $83.58 D  
Incentive Stock Option (right to buy)  (19)1/18/2032 Common Stock 383 $74.78 D  
Non-Qualified Stock Option (right to buy)  (20)1/18/2032 Common Stock 2240 $74.78 D  

Explanation of Responses:
(1) Represents restricted stock units ("RSUs") granted on July 2, 2018 that will vest fully on July 2, 2022.
(2) Represents restricted stock units ("RSUs") granted on July 2, 2019 that will vest 943 on July 2, 2022 and the remaining on July 2, 2023.
(3) Represents restricted stock units ("RSUs") granted on January 17, 2020 that will vest fully on January 17, 2024.
(4) Represents restricted stock units ("RSUs") granted on July 2, 2020 that will vest 774 on July 2, 2022, July 2, 2023 and July 2, 2024.
(5) Represents restricted stock units ("RSUs") granted on July 2, 2021 that will vest 912 on July 2, 2022, July 2, 2023, July 2, 2024 and the remaining will vest on July 2, 2025.
(6) As of March 11,2022, the award is fully vested and exercisable.
(7) Option granted on July 2, 2018 and becomes exercisable on July 2,2022.
(8) Options granted on July 2, 2018 and will vest monthly through July 2,2022.
(9) Options granted on January 4, 2019 and become exercisable in full on January 4, 2023.
(10) Options granted on January 4, 2019 and vest monthly through July 2,2022.
(11) Options granted on July 2, 2019 and vest monthly through July 2,2023.
(12) Options granted on January 17, 2020 and vest monthly through July 2,2023.
(13) Options granted on July 2, 2020 and will vest monthly starting January 2, 2024 through July 2, 2024.
(14) Options granted on July 2, 2020 and will vest monthly through December 2, 2023.
(15) Options granted on January 15, 2021 and will vest monthly starting January 2, 2024 through July 2, 2024
(16) Options granted on January 15, 2021 and will vest monthly through December 2, 2023.
(17) Options granted on July 2, 2021 and will vest monthly starting January 2, 2024 through July 2, 2025.
(18) Options granted on July 2, 2021 with 655 vesting on July 2, 2022 and the remainder vesting monthly through December 2, 2024.
(19) Options granted on January 19, 2022 and will vest monthly starting January 2, 2025 through July 2, 2025.
(20) Options granted on January 19, 2022 with 655 vesting on July 2, 2022 and the remainder vesting monthly through December 2, 2024.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Tray Thomas
1801 AUGUSTINE CUT-OFF
WILMINGTON, DE 19803


Principal Accounting Officer

Signatures
/s/ Elizabeth Feeney3/23/2022
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Incyte Charts.
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Incyte Charts.